DV
Delphi Ventures
Venture CapitalActiveDelphi Ventures was founded over 25 years ago as one of the first venture capital firms to focus on investing in life sciences companies.
San Mateo, United StatesFounded 1998
145
Investments
38
Exits
—
AUM
26.2%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Delphi Ventures.
Investment Thesis & Strategy
Delphi Ventures invests in various stages of fintech companies, leveraging its extensive experience in the life sciences sector to identify and support innovative financial technology solutions.
Investment Activity
Deals per year over the last 5 years
1
20051
20061
20070
20081
2009Portfolio Companies
Selected investments from their portfolio of 145 companies
N
NPS Pharmaceuticals
Biotech · Series A, 0
E
Exelixis
Biotech · Series A, 0
A
Acadia Pharmaceuticals
Biotech · Series A, 0
S
Seattle Genetics
Biotech · Series A, 0
S
Sangamo Therapeutics
Biotech · Series A, 0
O
Onyx Pharmaceuticals
Biotech · Series A, 0
I
Idenix Pharmaceuticals
Biotech · Series A, 0
N
Neurocrine Biosciences
Biotech · Series A, 0
A
Aragon Pharmaceuticals
Biotech · Series A, 2009
E
Epizyme
Biotech · Series A, 2007
P
Pharmacyclics
Biotech · Series B, 2006
P
Portola Pharmaceuticals
Biotech · Series A, 2005
Frequently Asked Questions
Delphi Ventures focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Sierra Ventures
San Mateo, United States · 319 deals
Mohr Davidow Ventures
San Mateo, United States · 295 deals
Draper Associates
San Mateo, United States · 252 deals
Emergence
San Mateo, United States · 184 deals
DNX Ventures
San Mateo, United States · 164 deals
Worldview Technology Partners
San Mateo, United States · 135 deals